TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Q2 2024 vs. Q1 2024
How the institutions holding TriSalus Life Sciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 2.59M | 2.16M | −428.9K (−16.6%) |
| Value | $3.33M | $3.71M | +$375.6K (+11.3%) |
New holders (2)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bluefin Capital Management, LLC | 115,989 | $211.1K | 0.06% |
| Cable Car Capital LLC | 76,287 | $124.3K | 0.13% |
Sold out (5)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Highbridge Capital Management LLC | – | $662.1K |
| Exos Asset Management LLC | 167,610 | $167.6K |
| Wolverine Asset Management LLC | 117,290 | $117.3K |
| Aristeia Capital LLC | 53,561 | $58.9K |
| Clear Street LLC | 41,169 | $41.2K |